Skip to Main Content

MIND: Artemis in the Removal of Intracerebral Hemorrhage

Conditions

Diseases of the Nervous System

What is the purpose of this trial?

Brief Summary:

The primary objective of this multicenter randomized controlled study is to compare the safety and efficacy of minimally invasive hematoma evacuation with the Artemis Neuro Evacuation Device to best medical management for the treatment of intracerebral hemorrhage (ICH).

  • Trial with
    Penumbra Inc.
  • Start Date
    12/03/2019
  • End Date
    02/27/2021
Trial Image

For more information about this study, contact:

Lindsey Fraczkiewicz

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    12/06/2019
  • Study HIC
    #2000025394